# Subcutaneous Immunotherapy for Mouse in Adults

> **NCT02532179** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 12 (actual)

## Conditions studied

- Asthma
- Perennial Allergic Rhinitis

## Interventions

- **BIOLOGICAL:** Mouse Allergenic Extract

## Key facts

- **NCT ID:** NCT02532179
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2018-03-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02532179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02532179, "Subcutaneous Immunotherapy for Mouse in Adults". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02532179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*